Document is current
Any future updates will be listed below
-
Authors
Zhu, Bokai https://orcid.org/0000-0003-3599-9419
Bai, Yunhao
Yeo, Yao Yu https://orcid.org/0000-0002-7604-2296
Lu, Xiaowei
Rovira-Clavé, Xavier
Chen, Han
Yeung, Jason
Nkosi, Dingani
Glickman, Jonathan
Delgado-Gonzalez, Antonio https://orcid.org/0000-0002-4760-8174
Gerber, Georg K. https://orcid.org/0000-0002-9149-5509
Angelo, Mike https://orcid.org/0000-0003-1531-5067
Shalek, Alex K. https://orcid.org/0000-0001-5670-8778
Nolan, Garry P. https://orcid.org/0000-0002-8862-9043
Jiang, Sizun https://orcid.org/0000-0001-6149-3142
- License Information
-
More Information
Article History
Received: 26 April 2024
Accepted: 13 January 2025
First Online: 31 January 2025
Competing interests
: S.J. is a co-founder of Elucidate Bio Inc, and serves on its Board of Directors and Scientific Advisory Board, and acknowledges research support from Roche. G.P.N. received research grants from Pfizer, Inc.; Vaxart, Inc.; Celgene, Inc.; and Juno Therapeutics, Inc. during the time of and unrelated to this work. G.P.N. and M.A. are co-founders of Ionpath Inc. G.P.N. is a co-founder of Akoya Biosciences, Inc., inventor on patent US9909167, and is a Scientific Advisory Board member for Akoya Biosciences, Inc. M.A. is a Scientific Advisory Board member for Ionpath Inc. A.K.S. reports compensation for consulting and/or scientific advisory board membership from Honeycomb Biotechnologies, Cellarity, Ochre Bio, Relation Therapeutics, IntrECate Biotherapeutics, Bio-Rad Laboratories, Fogpharma, Passkey Therapeutics, Senda Biosciences and Dahlia Biosciences unrelated to this work. The other authors declare no competing interests.
